From May 30, 2022 to May 31, 2022, the company has repurchased 22,700 shares, representing 0.67% for ¥29.21 million. With this, the company has completed the repurchase of 22,700 shares, representing 0.67% for ¥29.21 million under the buyback announced on May 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 JPY | -0.10% |
|
-0.20% | +0.60% |
1st Jan change | Capi. | |
---|---|---|
+0.60% | 21.32M | |
-12.89% | 8.09B | |
+25.26% | 1.22B | |
-8.33% | 354M | |
+6.43% | 280M | |
+8.33% | 225M | |
-47.95% | 80.29M | |
-28.44% | 70.28M | |
+28.50% | 63.87M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.